| Year |
Citation |
Score |
| 2023 |
Trivedi T, Manaa M, John S, Reiken S, Murthy S, Pagnotti GM, Dole NS, She Y, Suresh S, Hain BA, Regan J, Ofer R, Wright L, Robling A, Cao X, ... ... Mohammad KS, et al. Zoledronic acid improves bone quality and muscle function in a high bone turnover state. Biorxiv : the Preprint Server For Biology. PMID 37333318 DOI: 10.1101/2023.06.01.543305 |
0.377 |
|
| 2022 |
Pagnotti GM, Trivedi T, Mohammad KS. Translational Strategies to Target Metastatic Bone Disease. Cells. 11. PMID 35455987 DOI: 10.3390/cells11081309 |
0.381 |
|
| 2021 |
Trivedi T, Pagnotti GM, Guise TA, Mohammad KS. The Role of TGF-β in Bone Metastases. Biomolecules. 11. PMID 34827641 DOI: 10.3390/biom11111643 |
0.331 |
|
| 2020 |
Singh P, Mohammad KS, Pelus LM. CXCR4 expression in the bone marrow microenvironment is required for hematopoietic stem and progenitor cell maintenance and early hematopoietic regeneration after myeloablation. Stem Cells (Dayton, Ohio). PMID 32159901 DOI: 10.1002/Stem.3174 |
0.368 |
|
| 2019 |
Saito H, Gasser A, Bolamperti S, Maeda M, Matthies L, Jähn K, Long CL, Schlüter H, Kwiatkowski M, Saini V, Pajevic PD, Bellido T, van Wijnen AJ, Mohammad KS, Guise TA, et al. TG-interacting factor 1 (Tgif1)-deficiency attenuates bone remodeling and blunts the anabolic response to parathyroid hormone. Nature Communications. 10: 1354. PMID 30902975 DOI: 10.1038/S41467-019-08778-X |
0.466 |
|
| 2019 |
Waning DL, Guise TA, Mohammad KS. A "Connexin" Responsible for the Fatal Attraction of Cancer to Bone. Cell Metabolism. 29: 6-8. PMID 30625309 DOI: 10.1016/J.Cmet.2018.12.014 |
0.425 |
|
| 2019 |
Wright LE, Suresh S, Regan JN, Pagnotti GM, John S, Mohammad KS, Guise TA. Exposure to Adipose-Enriched Bone Marrow Increased Breast Cancer Cell Expression of Genes that Drive Tumor Metastasis Proceedings of Imprs. 2. DOI: 10.18060/23635 |
0.35 |
|
| 2018 |
Petrusca DN, Toscani D, Wang FM, Park C, Crean CD, Anderson JL, Marino S, Mohammad KS, Zhou D, Silbermann R, Sun Q, Kurihara N, Galson DL, Giuliani N, Roodman GD. Growth factor independence 1 expression in myeloma cells enhances their growth, survival, and osteoclastogenesis. Journal of Hematology & Oncology. 11: 123. PMID 30286780 DOI: 10.1186/S13045-018-0666-5 |
0.321 |
|
| 2017 |
Mohammad KS, Guise TA. Breaking Down Barriers to Chemoresistance: Role of Chemotherapy-Induced Osteoblastic Jagged1. Cancer Cell. 32: 717-718. PMID 29232546 DOI: 10.1016/j.ccell.2017.11.016 |
0.424 |
|
| 2017 |
Dole NS, Mazur CM, Acevedo C, Lopez JP, Monteiro DA, Fowler TW, Gludovatz B, Walsh F, Regan JN, Messina S, Evans DS, Lang TF, Zhang B, Ritchie RO, Mohammad KS, et al. Osteocyte-Intrinsic TGF-β Signaling Regulates Bone Quality through Perilacunar/Canalicular Remodeling. Cell Reports. 21: 2585-2596. PMID 29186693 DOI: 10.1016/J.Celrep.2017.10.115 |
0.398 |
|
| 2017 |
Ross MH, Esser AK, Fox GC, Schmieder AH, Yang X, Hu G, Pan D, Su X, Xu Y, Novack DV, Walsh T, Colditz GA, Lukaszewicz GH, Cordell E, Novack JS, ... ... Mohammad KS, et al. Bone-induced expression of integrin β3 enables targeted nanotherapy of breast cancer metastases. Cancer Research. PMID 28855208 DOI: 10.1158/0008-5472.Can-17-1225 |
0.361 |
|
| 2017 |
Roth AA, Tang PC, Ye MJ, Mohammad KS, Nelson RF. Improved autologous cortical bone harvest and viability with 2Flute otologic burs. The Laryngoscope. PMID 28699273 DOI: 10.1002/lary.26779 |
0.447 |
|
| 2016 |
Bonetto A, Kays JK, Parker VA, Matthews RR, Barreto R, Puppa MJ, Kang KS, Carson JA, Guise TA, Mohammad KS, Robling AG, Couch ME, Koniaris LG, Zimmers TA. Differential Bone Loss in Mouse Models of Colon Cancer Cachexia. Frontiers in Physiology. 7: 679. PMID 28123369 DOI: 10.3389/fphys.2016.00679 |
0.409 |
|
| 2016 |
Wright LE, Harhash AA, Kozlow WM, Waning DL, Regan JN, She Y, John SK, Murthy S, Niewolna M, Marks AR, Mohammad KS, Guise TA. Aromatase inhibitor-induced bone loss increases the progression of estrogen receptor-negative breast cancer in bone and exacerbates muscle weakness in vivo. Oncotarget. PMID 28039445 DOI: 10.18632/Oncotarget.14139 |
0.411 |
|
| 2016 |
Zhang P, Xing C, Rhodes SD, He Y, Deng K, Li Z, He F, Zhu C, Nguyen L, Zhou Y, Chen S, Mohammad KS, Guise TA, Abdel-Wahab O, Xu M, et al. Loss of Asxl1 Alters Self-Renewal and Cell Fate of Bone Marrow Stromal Cell, Leading to Bohring-Opitz-like Syndrome in Mice. Stem Cell Reports. PMID 27237378 DOI: 10.1016/J.Stemcr.2016.04.013 |
0.329 |
|
| 2016 |
Delgado-Calle J, Anderson J, Cregor MD, Hiasa M, Chirgwin JM, Carlesso N, Yoneda T, Mohammad KS, Plotkin LI, Roodman GD, Bellido T. Bidirectional Notch Signaling and Osteocyte-Derived Factors in the Bone Marrow Microenvironment Promote Tumor Cell Proliferation and Bone Destruction in Multiple Myeloma. Cancer Research. 76: 1089-100. PMID 26833121 DOI: 10.1158/0008-5472.CAN-15-1703 |
0.455 |
|
| 2015 |
Waning DL, Mohammad KS, Reiken S, Xie W, Andersson DC, John S, Chiechi A, Wright LE, Umanskaya A, Niewolna M, Trivedi T, Charkhzarrin S, Khatiwada P, Wronska A, Haynes A, et al. Excess TGF-β mediates muscle weakness associated with bone metastases in mice. Nature Medicine. PMID 26457758 DOI: 10.1038/Nm.3961 |
0.311 |
|
| 2015 |
Teramachi J, Silbermann R, Yang P, Zhao W, Mohammad KS, Guo J, Anderson JL, Zhou D, Feng R, Myint KZ, Maertz N, Beumer JH, Eiseman JL, Windle JJ, Xie XQ, et al. Blocking the ZZ domain of sequestosome 1/p62 suppresses myeloma growth and osteoclast formation in vitro and induces dramatic bone formation in myeloma-bearing bones in vivo. Leukemia. PMID 26286116 DOI: 10.1038/leu.2015.229 |
0.437 |
|
| 2015 |
Stayrook KR, Mack JK, Cerabona D, Edwards DF, Bui HH, Niewolna M, Fournier PG, Mohammad KS, Waning DL, Guise TA. TGFβ-Mediated induction of SphK1 as a potential determinant in human MDA-MB-231 breast cancer cell bone metastasis. Bonekey Reports. 4: 719. PMID 26157579 DOI: 10.1038/Bonekey.2015.88 |
0.337 |
|
| 2015 |
Wu C, Rankin EB, Castellini L, Alcudia JF, LaGory EL, Andersen R, Rhodes SD, Wilson TL, Mohammad KS, Castillo AB, Guise TA, Schipani E, Giaccia AJ. Corrigendum: Oxygen-sensing PHDs regulate bone homeostasis through the modulation of osteoprotegerin. Genes & Development. 29: 1202. PMID 26063577 |
0.343 |
|
| 2015 |
Wu C, Rankin EB, Castellini L, Fernandez-Alcudia J, LaGory EL, Andersen R, Rhodes SD, Wilson TL, Mohammad KS, Castillo AB, Guise TA, Schipani E, Giaccia AJ. Oxygen-sensing PHDs regulate bone homeostasis through the modulation of osteoprotegerin. Genes & Development. 29: 817-31. PMID 25846796 DOI: 10.1101/Gad.255000.114 |
0.424 |
|
| 2015 |
Wright LE, Buijs JT, Kim HS, Coats LE, Scheidler AM, John SK, She Y, Murthy S, Ma N, Chin-Sinex HJ, Bellido TM, Bateman TA, Mendonca MS, Mohammad KS, Guise TA. Single-Limb Irradiation Induces Local and Systemic Bone Loss in a Murine Model. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 30: 1268-79. PMID 25588731 DOI: 10.1002/Jbmr.2458 |
0.473 |
|
| 2015 |
Delgado-Calle J, Anderson J, Cregor MD, Carlesso N, Mohammad KS, Plotkin LI, Bellido TM, Roodman GD. Bidirectional Notch Signaling Between Multiple Myeloma (MM) Cells and Osteocytes As a Potential Target to Inhibit Tumor Growth and Osteoclast Recruitment in MM Blood. 126: 2977-2977. DOI: 10.1182/Blood.V126.23.2977.2977 |
0.355 |
|
| 2014 |
Siclari VA, Mohammad KS, Tompkins DR, Davis H, McKenna CR, Peng X, Wessner LL, Niewolna M, Guise TA, Suvannasankha A, Chirgwin JM. Tumor-expressed adrenomedullin accelerates breast cancer bone metastasis. Breast Cancer Research : Bcr. 16: 458. PMID 25439669 DOI: 10.1186/S13058-014-0458-Y |
0.304 |
|
| 2013 |
Chiechi A, Waning DL, Stayrook KR, Buijs JT, Guise TA, Mohammad KS. Role of TGF-β in breast cancer bone metastases. Advances in Bioscience and Biotechnology (Print). 4: 15-30. PMID 24558636 DOI: 10.4236/Abb.2013.410A4003 |
0.348 |
|
| 2013 |
Waning DL, Mohammad KS, Guise TA. Cancer-associated osteoclast differentiation takes a good look in the miR(NA)ror. Cancer Cell. 24: 407-9. PMID 24135278 DOI: 10.1016/J.Ccr.2013.10.001 |
0.344 |
|
| 2013 |
Casimiro S, Mohammad KS, Pires R, Tato-Costa J, Alho I, Teixeira R, Carvalho A, Ribeiro S, Lipton A, Guise TA, Costa L. RANKL/RANK/MMP-1 molecular triad contributes to the metastatic phenotype of breast and prostate cancer cells in vitro. Plos One. 8: e63153. PMID 23696795 DOI: 10.1371/journal.pone.0063153 |
0.356 |
|
| 2013 |
Wright LE, Frye JB, Lukefahr AL, Timmermann BN, Mohammad KS, Guise TA, Funk JL. Curcuminoids block TGF-β signaling in human breast cancer cells and limit osteolysis in a murine model of breast cancer bone metastasis. Journal of Natural Products. 76: 316-21. PMID 23145932 DOI: 10.1021/Np300663V |
0.365 |
|
| 2012 |
Juárez P, Mohammad KS, Yin JJ, Fournier PG, McKenna RC, Davis HW, Peng XH, Niewolna M, Javelaud D, Chirgwin JM, Mauviel A, Guise TA. Halofuginone inhibits the establishment and progression of melanoma bone metastases. Cancer Research. 72: 6247-56. PMID 23002206 DOI: 10.1158/0008-5472.CAN-12-1444 |
0.351 |
|
| 2012 |
Pollari S, Käkönen RS, Mohammad KS, Rissanen JP, Halleen JM, Wärri A, Nissinen L, Pihlavisto M, Marjamäki A, Perälä M, Guise TA, Kallioniemi O, Käkönen SM. Heparin-like polysaccharides reduce osteolytic bone destruction and tumor growth in a mouse model of breast cancer bone metastasis. Molecular Cancer Research : McR. 10: 597-604. PMID 22522458 DOI: 10.1158/1541-7786.MCR-11-0482 |
0.358 |
|
| 2012 |
Nickerson NK, Mohammad KS, Gilmore JL, Crismore E, Bruzzaniti A, Guise TA, Foley J. Decreased autocrine EGFR signaling in metastatic breast cancer cells inhibits tumor growth in bone and mammary fat pad. Plos One. 7: e30255. PMID 22276166 DOI: 10.1371/journal.pone.0030255 |
0.322 |
|
| 2012 |
Rhodes SD, He Y, Chen S, Yang H, Menon KM, Staser K, Yang X, Mohammad KS, Guise T, Xu M, Yang F. Haploinsufficiency of Nf1 in Myeloid Lineages Contributes to Neurofibromatosis Type 1 Associated Skeletal Deficits Blood. 120: 830-830. DOI: 10.1182/Blood.V120.21.830.830 |
0.371 |
|
| 2011 |
Clines GA, Mohammad KS, Grunda JM, Clines KL, Niewolna M, McKenna CR, McKibbin CR, Yanagisawa M, Suva LJ, Chirgwin JM, Guise TA. Regulation of postnatal trabecular bone formation by the osteoblast endothelin A receptor. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 26: 2523-36. PMID 21698666 DOI: 10.1002/jbmr.450 |
0.39 |
|
| 2011 |
Mohammad KS, Javelaud D, Fournier PG, Niewolna M, McKenna CR, Peng XH, Duong V, Dunn LK, Mauviel A, Guise TA. TGF-beta-RI kinase inhibitor SD-208 reduces the development and progression of melanoma bone metastases. Cancer Research. 71: 175-84. PMID 21084275 DOI: 10.1158/0008-5472.Can-10-2651 |
0.342 |
|
| 2011 |
Juarez* P, Mohammad K, Mckenna R, Walton H, Niewolna M, Chirgwin J, Guise T. Halofuginone reduces bone metastases: TGF-β-dependent and independent effects Bone. 48: S19-S20. DOI: 10.1016/j.bone.2010.10.050 |
0.332 |
|
| 2009 |
Dunn LK, Mohammad KS, Fournier PG, McKenna CR, Davis HW, Niewolna M, Peng XH, Chirgwin JM, Guise TA. Hypoxia and TGF-beta drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment. Plos One. 4: e6896. PMID 19727403 DOI: 10.1371/Journal.Pone.0006896 |
0.421 |
|
| 2009 |
Mohammad KS, Fournier PG, Guise TA, Chirgwin JM. Agents targeting prostate cancer bone metastasis. Anti-Cancer Agents in Medicinal Chemistry. 9: 1079-88. PMID 19719455 DOI: 10.2174/187152009789735008 |
0.37 |
|
| 2009 |
Mohammad KS, Chen CG, Balooch G, Stebbins E, McKenna CR, Davis H, Niewolna M, Peng XH, Nguyen DH, Ionova-Martin SS, Bracey JW, Hogue WR, Wong DH, Ritchie RO, Suva LJ, et al. Pharmacologic inhibition of the TGF-beta type I receptor kinase has anabolic and anti-catabolic effects on bone. Plos One. 4: e5275. PMID 19357790 DOI: 10.1371/Journal.Pone.0005275 |
0.437 |
|
| 2008 |
Mohammad KS, Chirgwin JM, Guise TA. Assessing new bone formation in neonatal calvarial organ cultures. Methods in Molecular Biology (Clifton, N.J.). 455: 37-50. PMID 18463809 DOI: 10.1007/978-1-59745-104-8_3 |
0.444 |
|
| 2007 |
Javelaud D, Mohammad KS, McKenna CR, Fournier P, Luciani F, Niewolna M, André J, Delmas V, Larue L, Guise TA, Mauviel A. Stable overexpression of Smad7 in human melanoma cells impairs bone metastasis. Cancer Research. 67: 2317-24. PMID 17332363 DOI: 10.1158/0008-5472.Can-06-3950 |
0.355 |
|
| 2007 |
Clines GA, Mohammad KS, Bao Y, Stephens OW, Suva LJ, Shaughnessy JD, Fox JW, Chirgwin JM, Guise TA. Dickkopf homolog 1 mediates endothelin-1-stimulated new bone formation. Molecular Endocrinology (Baltimore, Md.). 21: 486-98. PMID 17068196 DOI: 10.1210/me.2006-0346 |
0.391 |
|
| 2006 |
Guise TA, Mohammad KS, Clines G, Stebbins EG, Wong DH, Higgins LS, Vessella R, Corey E, Padalecki S, Suva L, Chirgwin JM. Basic mechanisms responsible for osteolytic and osteoblastic bone metastases. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 6213s-6216s. PMID 17062703 DOI: 10.1158/1078-0432.Ccr-06-1007 |
0.461 |
|
| 2004 |
Chirgwin JM, Mohammad KS, Guise TA. Tumor-bone cellular interactions in skeletal metastases Journal of Musculoskeletal Neuronal Interactions. 4: 308-318. PMID 15615499 |
0.426 |
|
| 2004 |
Neufeld DA, Hosman S, Yescas T, Mohammad K, Day F, Said S. Actin fiber patterns detected by Alexafluor 488 phalloidin suggest similar cell migration in regenerating and nonregenerating rodent toes. The Anatomical Record. Part a, Discoveries in Molecular, Cellular, and Evolutionary Biology. 278: 450-3. PMID 15103740 DOI: 10.1002/Ar.A.20033 |
0.511 |
|
| 2004 |
Guise TA, Mohammad KS. Endothelins in bone cancer metastases. Cancer Treatment and Research. 118: 197-212. PMID 15043194 |
0.418 |
|
| 2003 |
Mohammad KS, Guise TA. Mechanisms of osteoblastic metastases: role of endothelin-1. Clinical Orthopaedics and Related Research. S67-74. PMID 14600594 DOI: 10.1097/01.blo.0000093047.96273.4e |
0.394 |
|
| 2003 |
Yin JJ, Mohammad KS, Käkönen SM, Harris S, Wu-Wong JR, Wessale JL, Padley RJ, Garrett IR, Chirgwin JM, Guise TA. A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases. Proceedings of the National Academy of Sciences of the United States of America. 100: 10954-9. PMID 12941866 DOI: 10.1073/Pnas.1830978100 |
0.413 |
|
| 2003 |
Guise TA, Yin JJ, Mohammad KS. Role of endothelin-1 in osteoblastic bone metastases. Cancer. 97: 779-84. PMID 12548575 DOI: 10.1002/cncr.11129 |
0.438 |
|
| 2001 |
Mohammad KS, Yin JJ, Grubbs BG, Cui Y, Padley R, Guise TA. Endothelin-1 (ET-1) mediates pathological but not normal bone remodeling Breast Cancer Research and Treatment. 69: 212. |
0.441 |
|
| 2000 |
Neufeld DA, Mohammad KS. Fluorescent bone viewed through toenails of living animals: a method to observe bone regrowth. Biotechnic & Histochemistry : Official Publication of the Biological Stain Commission. 75: 259-63. PMID 11131566 DOI: 10.3109/10520290009085129 |
0.591 |
|
| 2000 |
Mohammad KS, Neufeld DA. Denervation retards but does not prevent toetip regeneration. Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society. 8: 277-81. PMID 11013019 DOI: 10.1046/J.1524-475X.2000.00277.X |
0.59 |
|
| 1999 |
Mohammad KS, Day FA, Neufeld DA. Bone growth is induced by nail transplantation in amputated proximal phalanges. Calcified Tissue International. 65: 408-10. PMID 10541769 DOI: 10.1007/S002239900722 |
0.555 |
|
| Show low-probability matches. |